Common use of Descriptive ACO Materials and Activities Clause in Contracts

Descriptive ACO Materials and Activities. ‌ 1. The ACO shall not use, and shall prohibit its Next Generation Participants and Preferred Providers from using Descriptive ACO Materials or Activities until reviewed and approved by CMS. 2. Descriptive ACO Materials or Activities are deemed approved 10 business days following their submission to CMS if: (a) The ACO certifies in writing its compliance with all the requirements under this Section V.E; and (b) CMS does not disapprove the Descriptive ACO Materials or Activities. 3. CMS may issue written notice of disapproval of Descriptive ACO Materials or Activities at any time, including after the expiration of the 10 day review period. 4. The ACO, Next Generation Participants, Preferred Providers, or any other individuals or entities performing functions or services related to ACO activities, as applicable, must immediately discontinue use of any Descriptive ACO Materials or Activities disapproved by CMS. 5. Any material changes to CMS-approved Descriptive ACO Materials and Activities must be reviewed and approved by CMS before use. 6. The ACO shall retain copies of all written and electronic Descriptive ACO Materials and Activities and appropriate records for all other Descriptive ACO Materials and Activities provided to Next Generation Beneficiaries in a manner consistent with Section XVIII.

Appears in 4 contracts

Samples: Next Generation Aco Model Participation Agreement, Next Generation Aco Model Participation Agreement, Next Generation Aco Model Participation Agreement

AutoNDA by SimpleDocs

Descriptive ACO Materials and Activities. ‌ 1. The ACO shall not use, and shall prohibit its Next Generation Participants and Preferred Providers from using Descriptive ACO Materials or Activities until reviewed and approved in their entirety by CMS. 2. Descriptive ACO Materials or Activities are deemed approved 10 business days following their submission to CMS if: (a) The ACO certifies in writing its compliance with all the marketing requirements under this Section V.Esection; and (b) CMS does not disapprove the Descriptive ACO Materials or Activities. 3. CMS may issue written notice of disapproval of Descriptive ACO Materials or Activities at any time, including after the expiration of the 10 day review period. 4. The ACO, Next Generation Participants, Preferred Providers, or any other individuals or entities performing functions or services related to ACO activities, as applicable, must immediately discontinue use of any Descriptive ACO Materials or Activities disapproved by CMS. 5. Any material changes to CMS-approved Descriptive ACO Materials and Activities must be reviewed and approved by CMS before use. 6. The ACO shall retain copies of all written and electronic Descriptive ACO Materials and Activities and appropriate records for all other Descriptive ACO Materials and Activities provided to Next Generation Beneficiaries in a manner consistent with Section XVIII.

Appears in 1 contract

Samples: Next Generation Aco Model Participation Agreement

AutoNDA by SimpleDocs

Descriptive ACO Materials and Activities. 1. The ACO shall not use, and shall prohibit its Next Generation Participants and Preferred Providers from using Descriptive ACO Materials or Activities until reviewed and approved in their entirety by CMS. 2. Descriptive ACO Materials or Activities are deemed approved 10 business days following their submission to CMS if: (a) The ACO certifies in writing its compliance with all the marketing requirements under this Section V.Esection; and (b) CMS does not disapprove the Descriptive ACO Materials or Activities. 3. CMS may issue written notice of disapproval of Descriptive ACO Materials or Activities at any time, including after the expiration of the 10 day review period. 4. The ACO, Next Generation Participants, Preferred Providers, or any other individuals or entities performing functions or services related to ACO activities, as applicable, must immediately discontinue use of any Descriptive ACO Materials or Activities disapproved by CMS. 5. Any material changes to CMS-approved Descriptive ACO Materials and Activities must be reviewed and approved by CMS before use. 6. The ACO shall retain copies of all written and electronic Descriptive ACO Materials and Activities and appropriate records for all other Descriptive ACO Materials and Activities provided to Next Generation Beneficiaries in a manner consistent with Section XVIII.

Appears in 1 contract

Samples: Participation Agreement (Apollo Medical Holdings, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!